Stocks of Henry Schein Inc. (NASDAQ:HSIC) traded higher last session on Wall Street, down -2.86% to $80.03.
HSIC stock price is now 2.34% away from the 50-day moving average and 2.11% away from the 200-day moving average. The market capitalization of the company currently stands at $10.95B.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
With the price target maintained at $80, UBS recently Upgraded its rating from Sell to Neutral for Henry Schein Inc. (NASDAQ: HSIC). On July 21, 2022, Goldman Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $93 to quote $85, while ‘Robert W. Baird’ rates the stock as ‘Neutral’.
In other news, Connett Bradford C, CEO, NA Distribution Group sold 6,840 shares of the company’s stock on Dec 21. The stock was sold for $552,056 at an average price of $80.71. Upon completion of the transaction, the CEO, NA Distribution Group now directly owns 55,412 shares in the company, valued at $4.43 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 20, SVP, Chief Human Res. Officer McGlynn Lorelei sold 15,341 shares of the business’s stock. A total of $1,238,049 was realized by selling the stock at an average price of $80.70. This leaves the insider owning 73,753 shares of the company worth $5.9 million. Insiders disposed of 321,000 shares of company stock worth roughly $25.69 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HSIC stock. A new stake in Henry Schein Inc. shares was purchased by HRT FINANCIAL LP during the first quarter worth $14,544,000. MARSHALL WACE, LLP invested $8,633,000 in shares of HSIC during the first quarter. In the first quarter, PINEBRIDGE INVESTMENTS, L.P. acquired a new stake in Henry Schein Inc. valued at approximately $7,355,000. SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC acquired a new stake in HSIC for approximately $6,032,000. CITADEL ADVISORS LLC purchased a new stake in HSIC valued at around $5,202,000 in the second quarter. In total, there are 852 active investors with 99.90% ownership of the company’s stock.
Thursday’s opening bell rang with an opening price of $81.98 for Henry Schein Inc. (NASDAQ: HSIC). During the past 12 months, Henry Schein Inc. has had a low of $64.75 and a high of $92.68. As of last week, the company has a debt-to-equity ratio of 0.29, a current ratio of 1.80, and a quick ratio of 1.00. The fifty day moving average price for HSIC is $78.39 and a two-hundred day moving average price translates $78.33 for the stock.
The latest earnings results from Henry Schein Inc. (NASDAQ: HSIC) was released for Jun, 2022. According to the Medical Distribution Company, earnings per share came in at $1.16, inline with analysts’ expectations of $1.16. This compares to $1.20 EPS in the same period last year. The net profit margin was 5.10% and return on equity was 18.00% for HSIC. The company reported revenue of $3.07 billion for the quarter, compared to $3.18 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -3.49 percent. For the current quarter, analysts expect HSIC to generate $3.19B in revenue.
Henry Schein Inc.(HSIC) Company Profile
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
